Houston, TX – According to filings with the U.S. Securities and Exchange Commission, Luna Genetics is raising $2,000,000.00 in new funding. Sources indicate as part of senior management President, Arthur Beaudet played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Luna Genetics

Luna Genetics intends to establish a new, higher, standard of care for NIPT. Our test, currently under development, will capture whole fetal cells circulating in maternal blood, This will allow our CLIA certified CAP accredited clinical laboratory to perform true diagnostic testing for an ever growing number of severe genetic disorders. Furthermore, if women send their blood sample early enough in pregnancy, Luna Genetics will return test results to them and their doctors early enough in gestation so that they will have ample time to make a decision about a finding that indicates the presence of a severe disorder. .

To learn more about Luna Genetics, visit http://lunagenetics.com/

Contact:
Arthur Beaudet, President
346-355-0111

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved